Page last updated: 2024-09-03

dihydrosanguinarine and Pancreatic Neoplasms

dihydrosanguinarine has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, XY; Deng, L; Liu, P; Pang, P; Shi, YC; Wu, SZ; Wu, XL; Xu, HC; Zhou, GX	1

Other Studies

1 other study(ies) available for dihydrosanguinarine and Pancreatic Neoplasms

Article	Year
Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 59 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzophenanthridines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; MAP Kinase Signaling System; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins p21(ras); raf Kinases; ras Proteins; Tumor Suppressor Protein p53	2019

Article

Year

Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 59

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzophenanthridines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; MAP Kinase Signaling System; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins p21(ras); raf Kinases; ras Proteins; Tumor Suppressor Protein p53

2019